Robinhood is the newest way to buy and sell stocks without paying any brokerage fee. Penny Stocks on Robinhood are quite searched by people who are looking forward to making investments without spending a lot of money on the same. Finding penny stocks and putting the value as low as $100 for investment will make you get hundreds to thousands of stocks within the smallest investment. The investor could potentially make good money by trading on these stocks. The normal broker or online trading services charge a fee for buying or selling the stocks. It doesn’t appear big when you are getting profits but during the loss phases, the fee seems hefty and makes you feel miserable.
Penny stocks go up and down and using Robinhood App, it is easy to see the movements of stocks in the most appropriate way. If you are spending enough time on the stocks then it would be easy to make money by trading penny stocks on Robinhood. The reality is that your dedicated time and efforts are required to get ahead with the buying and selling of Robinhood stocks in the most rewarding manner. Buying the stocks with no trading fee will be fascinating but ultimately, it is your decision to go ahead and buy shares of good companies or EFTs. Robinhood focuses on trading the low-priced stocks on the major stock exchanges and doesn’t promote OTC or pink sheet options for investment.
Penny Stocks on Robinhood 2019
Below are some of the penny stocks on Robinhood platform this year which could be considered for the best prospects:
Interpace Diagnostics Group Inc. (NASDAQ: IDXG)
Interpace Diagnostics Group Inc. was founded in 1986 and works for the development and commercialization of molecular diagnostic tests for detection of genetic and molecular variations in case of acute cancers. The company’s customers are mainly hospitals, general physicians and hospitals. The stocks are at the level of $0.70 and could proceed towards higher range with the lined testing phases.
CHF Solutions (NASDAQ: CHFS)
CHF Solutions Inc. is a medical device company focusing on the provision of patient solutions for the people suffering from fluid overloading. The company’s major product is used as ultrafiltration treatment for managing fluid overload for the patients requiring hospitalization due to failure of diuretic therapy. The company is launching the Ultrafiltration programs in various locations. The day range of the stocks is around $4 and the company could reach towards its potential value of $53 which was the highest point in the previous year.
BioPharmX Corporation (NYSE: BPMX)
BioPharmX Corporation is a specialty based pharmaceutical company working for development and commercialization if the OTC products and prescription elements addressing the women’s and dermatology health markets. The various tests are conducted by the company for different phased trials and it is leading towards the successful runs which could lead to the betterment of the company’s stock values. The stocks are ranging at a value of $0.0725 and with the progress of trials, the probability is towards the higher side to gauge profits.